Health-care companies rose amid deal activity.

Shares of mental-illness drug developer Intra-Cellular rallied after health-care conglomerate Johnson & Johnson agreed to buy it for $15 billion, evidence of the pharmaceutical industry's renewed interest in neuroscience prospects.

Eli Lilly has agreed to acquire Scorpion Therapeutics' breast cancer treatment program for up to $2.5 billion in cash, and subsequent payments contingent upon the achievement of regulatory and sales milestones.

Sage Therapeutics jumped after confirming that larger biotech rival Biogen made an unsolicited offer to acquire all the Sage shares it doesn't already own for $7.22 apiece.

Moderna shares slid after the vaccine maker's 2025 revenue projection trailed Wall Street expectations.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

01-13-25 1709ET